Institution profile

医療法人愛誠会つかはらクリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02E2410002 +3

Location

Prefecture
Osaka
Address
大阪市阿倍野区阿倍野筋1丁目1-43 あべのハルカス22F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 一般社団法人再生医療安全未来委員会 安全未来特定認定再生医療等委員会
  • 医療法人清悠会 認定再生医療等委員会
  • カメイクリニック2認定再生医療等委員会

Public score

60.7/ 100

A · Review level
25.0 / 30
B · Technologies
18.5 / 35
C · Coverage
14.3 / 25
D · Class I / II technologies
2.9 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 60.7
Public score →100

Registered technologies (4)

Stem cells (all sources) 1
Registered technologies · Japanese originalTechnology areasPlan classification
アトピー性皮膚炎患者の主症状に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
Adipose-derived stem cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
アトピー性皮膚炎患者の主症状に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
PRP and platelet-derived 1
Registered technologies · Japanese originalTechnology areasPlan classification
多血小板血漿を用いた皮膚再生治療PRP and platelet-derivedSkinClass III
NK and immune cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
悪性腫瘍の予防に対する自家NK細胞療法NK and immune cellsClass III
悪性腫瘍に対する自家活性化NK細胞療法NK and immune cellsClass III
Skin 2
Registered technologies · Japanese originalTechnology areasPlan classification
アトピー性皮膚炎患者の主症状に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
多血小板血漿を用いた皮膚再生治療PRP and platelet-derivedSkinClass III

Certified committee for regenerative medicine

  • 一般社団法人再生医療安全未来委員会 安全未来特定認定再生医療等委員会
  • 医療法人清悠会 認定再生医療等委員会
  • カメイクリニック2認定再生医療等委員会

Public document number

  • 02E2410002
  • 01E2510021
  • 01E2510022
  • 03E2305040
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
アトピー性皮膚炎患者の主症状に対する自己脂肪由来幹細胞による治療Class II一般社団法人再生医療安全未来委員会 安全未来特定認定再生医療等委員会02E2410002
悪性腫瘍の予防に対する自家NK細胞療法Class III医療法人清悠会 認定再生医療等委員会01E2510021
悪性腫瘍に対する自家活性化NK細胞療法Class III医療法人清悠会 認定再生医療等委員会01E2510022
多血小板血漿を用いた皮膚再生治療Class IIIカメイクリニック2認定再生医療等委員会03E2305040

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor